| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/01/2006 | US7084123 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083947 Assay techniques using nematode worms |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083937 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 08/01/2006 | US7083820 Dehydration and stabilization of naturally occurring substance containing biologically active components, e.g. proteins, by heating with a microbiocide at a temperature below denaturization; food processing; drugs; cosmetics |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/01/2006 | CA2234611C New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 08/01/2006 | CA2198701C Substituted 9-alkyladenines |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006079077A2 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
| 07/27/2006 | WO2006078697A1 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/27/2006 | WO2006078606A2 Ati receptor antagonists for treating vascular inflammation |
| 07/27/2006 | WO2006078605A1 Methods of use of dual ppar agonist compounds and drug delivery devices containing such compounds |
| 07/27/2006 | WO2006078524A1 Methods for qt interval control |
| 07/27/2006 | WO2006078422A2 Methods for modulating tumor growth and metastasis |
| 07/27/2006 | WO2006078257A1 Substituted fullerene compositions and their use in treatment of shock |
| 07/27/2006 | WO2006078223A1 Angiotensin i derivatives |
| 07/27/2006 | WO2006078034A1 Cells capable of differentiating into cardiac muscle cells |
| 07/27/2006 | WO2006077975A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077972A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077821A1 Aromatic sulfone compound as aldosterone receptor modulator |
| 07/27/2006 | WO2006077675A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | WO2006077614A1 Hmgb1 inhibitors and antagonists for the inhibition of atherosclerosis pathogenesis and development |
| 07/27/2006 | WO2006076797A1 Cathepsin k inhibitors and atherosclerosis |
| 07/27/2006 | WO2006076767A1 A method of treating cellular damage |
| 07/27/2006 | WO2006062581A3 Delivery of therapeutic rnai agents for treating restenosis |
| 07/27/2006 | WO2006029052A3 Methods for assessing atherosclerosis |
| 07/27/2006 | WO2006008316A3 Selective inhibitors of human corticosteroid syntheses |
| 07/27/2006 | WO2005110480A3 Combination of organic compounds |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060167402 Method and composition for inhibiting cardiovascular cell proliferation |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167100 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 07/27/2006 | US20060167098 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
| 07/27/2006 | US20060167086 Medicinal composition |
| 07/27/2006 | US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167013 5-methyl-2-(1-piperazinyl)benzenesulfonic acid; sodium channel blocking agent; cardiovascular disorder : ischemic heart disease, reperfusion, heart failure, hypertension, angina pectoris, arrhythmia, postsurgery complications |
| 07/27/2006 | US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL) |
| 07/27/2006 | US20060166989 2-naphthamide derivatives |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 07/27/2006 | US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | US20060166948 Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166937 Bisphosphonates for the treatment of atherosclerosis and device comprising them |
| 07/27/2006 | US20060166899 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 07/27/2006 | US20060166894 Ace-inhibitors having antioxidant and no-donor activity |
| 07/27/2006 | US20060166873 Preventive/remedy for arteriosclerosis |
| 07/27/2006 | US20060166868 Vegf peptides and their use |
| 07/27/2006 | US20060166860 Zinc transporter compositions for the treatment of cardiovascular diseases |
| 07/27/2006 | US20060166255 Methods of using 48149, a human Aminopeptidase family member |
| 07/27/2006 | US20060165816 Herbal compositions useful as chemopreventive and therapeutic agents |
| 07/27/2006 | US20060165815 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 07/27/2006 | US20060165808 Microcapsules for the delayed, controlled release of perindopril |
| 07/27/2006 | US20060165771 Compositions for delivery of drug combinations |
| 07/27/2006 | US20060165757 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165695 Antibody against human insulin-like growth factor |
| 07/27/2006 | DE102005002500A1 Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen Tetrahydrofuran derivatives as inhibitors of matrix metalloproteinases |
| 07/27/2006 | CA2595599A1 Methods for qt interval control |
| 07/27/2006 | CA2595469A1 A method of treating cellular damage |
| 07/27/2006 | CA2594629A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | CA2593483A1 Methods of use of dual ppar agonist compounds and drug delivery devices containing such compounds |
| 07/27/2006 | CA2592500A1 Methods of increasing cerebral blood flow |
| 07/26/2006 | EP1683805A1 Novel inhibitor for advanced glycation endproduct formation and aldose reductase inhibitor |
| 07/26/2006 | EP1683798A1 Novel fused polycyclic compound having heterocycle and medicinal use thereof |
| 07/26/2006 | EP1683520A2 Water-soluble paclitaxel produgs |
| 07/26/2006 | EP1682153A2 Methods of modulating angiogenesis and cancer cell proliferation |
| 07/26/2006 | EP1682140A2 Methods of use of thrombin receptor antagonists |
| 07/26/2006 | EP1682122A1 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic |
| 07/26/2006 | EP1682111A1 Enos transcription enhancers for use in the cell therapy of ischemic heart diseases |
| 07/26/2006 | EP1682072A2 AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 07/26/2006 | EP1527063B1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1481065B1 Method for detection of leptin receptor ligands |
| 07/26/2006 | EP1414447B1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1357906B1 Blockade of sodium channels by phenol derivatives |
| 07/26/2006 | EP1349578B1 Medicinal association of a biguanine (metformin) and arginine |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1303294B1 Method for treating unstable angina pectoris |
| 07/26/2006 | EP1257297B1 Compositions and methods for treatemnt of angiogenesis in pathological lesions |